When was Thermosome founded?

Thermosome was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Thermosome located?

Thermosome is headquartered in Munich, Germany.

Which legal entities is Thermosome associated with?

Thermosome is associated with Thermosome Gmbh and 1 other.

How many employees does Thermosome have?

As of Sep 30, 2026, the latest employee count at Thermosome is 6.

Is Thermosome a funded company?

Thermosome is a funded company, having raised a total of $2.16M across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Apr 06, 2016.

When was the latest funding round of Thermosome?

Thermosome's latest funding was a $***** Seed round on Apr 06, 2016, with participation from 2 investors.

Where does Thermosome rank among its competitors?

Thermosome ranks 1291st amongst 3581 active competitors, of which 1186 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sana Biotechnology, which secured $25M in Aug, 2026.

Who are the top competitors of Thermosome?

Thermosome's top competitors include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Among them, Sana Biotechnology secured the most recent funding round in August, 2026.

Thermosome - 2026 Company Profile, Funding, Competitors & Financials

Thermosome is a seed company based in Munich (Germany), founded in 2014. It operates as a Developer of targeted tumor therapy combined with immune stimulation for cancer. Thermosome has raised $2.16M in funding from Bayern Kapital and HTGF. The company has 3581 active competitors, including 1186 funded and 803 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.

Company Details

Developer of targeted tumor therapy combined with immune stimulation for cancer. The company focuses on a new tumor targeting concept for increased local drug concentrations. This aims to achieve improved clinical treatment efficacy. The company is involved in drug development.

Website: www.thermosome.com/
Email ID: *****@thermosome.com

Key Metrics

Founded Year

2014

Location

Munich, Germany

Stage

Seed

Total Funding

$2.16M in 2 rounds

Latest Funding Round

Seed, Apr 06, 2016, $*****

Investors

Bayern Kapital & 16 more

Ranked

1291^st among 3581 active competitors

Employee Count

6 as on Sep 30, 2026

Similar Companies

Jazz Pharmaceuticals & 3301 more

View Thermosome's full profile

Thermosome is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Thermosome Gmbh CIN: D2601_HRB189433 , Germany, Active	Dec 17, 2010	-	-
Thermosome Gmbh CIN: HRB189433 , Germany, Active	Dec 16, 2010	-	-

Thermosome has raised a total funding of $2.16M over 2 rounds. Its first funding round was on Apr 06, 2016. Its latest funding round was a Seed round on Apr 06, 2016 for $*****. 2 investors participated in its latest round. Thermosome has 10 institutional investors and 7 angel investors.

Here is the list of recent funding rounds of Thermosome:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 06, 2016	4480525	Seed	3574922	9319021	7819858	1032734
Apr 06, 2016	4424729	Grant (prize money)	2367822	5146356	7595649	Bmbf

Access funding benchmarks and valuations. Sign up today!

View details of Thermosome's funding rounds and investors

Thermosome's employee count trend

Thermosome has 6 employees as of Sep 26. Here is Thermosome's employee count trend over the years:

Uncover Thermosome's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Thermosome include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of Thermosome, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	81/100
2nd	BeiGene 2010, Cambridge (United States), Public	Developer of targeted and immune-oncology drugs against cancer	$172M	Hillhouse, T. Rowe Price & 13 others	81/100
3rd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, PSP Investments & 18 others	74/100
4th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
5th	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Celadon Partners, Leaps by Bayer & 30 others	72/100
6th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
7th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
8th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	72/100
9th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	72/100
10th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
1291st	Thermosome 2014, Munich (Germany), Seed	Developer of targeted tumor therapy combined with immune stimulation for cancer	$2.16M	Coparion, Mpg & 15 others	37/100